Imaging technologies are being increasingly employed to guide the delivery of cancer therapies with the intent to increase their performance and efficacy.
To date, many patients have benefited from image-guided treatments through prolonged survival and improvements in quality of life. Advances in nanomedicine have enabled the development of multifunctional imaging agents that can further increase the performance of image-guided cancer therapy.
Our research is focused on the development of agents and tools that can further increase the performance of imaging in the therapy-guidance context. Specifically, we are active in the areas of image-guided surgery, personalized nanomedicine delivery, tracking of cell therapies and high-precision radiotherapy delivery.